Certain Stock Options of Eliem Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 6-FEB-2022. These Stock Options will be under lockup for 181 days starting from 9-AUG-2021 to 6-FEB-2022.

Details:
The directors, executive officers and the holders of substantially all of equity securities have agreed with the underwriters that for a period of 180 days, after the date of this prospectus, subject to specified exceptions as detailed further in “Underwriting” below, they will not, except with the prior written consent of SVB Leerink LLC and Evercore Group L.L.C., offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to sale of or otherwise dispose of or transfer any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock, request or demand that file a registration statement related to common stock, or enter into any swap or other agreement that transfers to another, in whole or in part, directly or indirectly, the economic consequence of ownership of the common stock.